Related Experiment Video

Updated: Jul 15, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

The incidence and risk factors for chronic graft-versus-host-disease

Jerzy Wojnar1, Sebastian Giebel, Aleksandra Holowiecka-Goral

  • 1Dept. of Haematology and Bone Marrow Transplantation, Silesian Medical University, Katowice, Poland. klinhem@slam.katowice.pl

Annals of Transplantation
|May 15, 2007
PubMed

Insights

Chronic graft-versus-host-disease (cGVHD) affects nearly half of patients post-allogeneic hematopoietic cell transplantation (alloHCT). Key risk factors include prior acute GVHD, older recipient age, and unrelated donors, guiding personalized treatment strategies.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Chronic graft-versus-host-disease (cGVHD) significantly impacts survival and quality of life following allogeneic hematopoietic cell transplantation (alloHCT).
  • Understanding the incidence and risk factors for cGVHD is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the incidence of cGVHD after alloHCT.
  • To identify recipient, donor, and procedure-related risk factors associated with cGVHD development.

Main Methods:

  • Analysis of 255 patients undergoing myeloablative alloHCT between 1992-2003.
  • Inclusion of patients who survived without disease progression.
  • Multivariate analysis to determine risk factors for overall and extensive cGVHD.

Main Results:

  • The cumulative incidence of overall and extensive cGVHD was 48% and 22%, respectively.
  • Risk factors for cGVHD included preceding acute GVHD, recipient age ≥40 years, unrelated donor hematopoietic cell transplantation (URD-HCT), chronic myeloid leukemia (CML) or myelodysplastic syndrome diagnosis, and CD3 cell dose.
  • Factors for extensive cGVHD included preceding acute GVHD, URD-HCT, CD3 cell dose >100 x 10^6/kg, and steroid use for acute GVHD prophylaxis.

Conclusions:

  • Multiple factors related to the recipient, donor, and transplant procedure influence the risk of cGVHD.
  • Individualized treatment approaches and modification of identified risk factors may enhance patient outcomes after alloHCT.
Abstract

More Related Videos

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...